000 01501 a2200409 4500
005 20250517224639.0
264 0 _c20190404
008 201904s 0 0 eng d
022 _a1873-2968
024 7 _a10.1016/j.bcp.2018.06.029
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aImpellizzeri, Daniela
245 0 0 _aTherapeutic potential of dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice by targeting IL-1β and IL-18.
_h[electronic resource]
260 _bBiochemical pharmacology
_c09 2018
300 _a150-161 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aColitis
_xchemically induced
650 0 4 _aDinitrofluorobenzene
_xanalogs & derivatives
650 0 4 _aDrug Delivery Systems
_xmethods
650 0 4 _aInterleukin 1 Receptor Antagonist Protein
_xadministration & dosage
650 0 4 _aInterleukin-18
_xantagonists & inhibitors
650 0 4 _aInterleukin-1beta
_xantagonists & inhibitors
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
700 1 _aSiracusa, Rosalba
700 1 _aCordaro, Marika
700 1 _aPeritore, Alessio Filippo
700 1 _aGugliandolo, Enrico
700 1 _aMancuso, Giuseppe
700 1 _aMidiri, Angelina
700 1 _aDi Paola, Rosanna
700 1 _aCuzzocrea, Salvatore
773 0 _tBiochemical pharmacology
_gvol. 155
_gp. 150-161
856 4 0 _uhttps://doi.org/10.1016/j.bcp.2018.06.029
_zAvailable from publisher's website
999 _c28590467
_d28590467